http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MY-124465-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8f70c5b59b293a0220e30a752bb017f |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
filingDate | 1996-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8f08c753af9901f0b6b28d19e9570ce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0c35739ea988f591dd9da28318601f3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d2a0c473d8abbbc808ce4f8c802ca5f |
publicationDate | 2006-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | MY-124465-A |
titleOfInvention | Reduction of infarct volume using citicoline |
abstract | THE INVENTION IS DIRECTED TO THE COMPOSITION AND USE OF CITICOLINE FOR THE PREPARATION OF A MEDICAMENT FOR REDUCING INFARCT VOLUME IN A PATIENT WHO HAS EXPERIENCED AN ISCHEMIC EVENT. A FIRST DOSE OF SAID MEDICAMENT COMPRISING AN EFFECTIVE AMOUNT OF CITICOLINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF IS ADMINISTERED SHORTLY AFTER AN ISCHEMIC EPISODE AND CONTINUING DAILY FOR UP TO ABOUT 30 DAYS, PREFERABLY FOR AT LEAST ABOUT 6 WEEKS. THE COMPOSITION COMPRISES OF AN EFFECTIVE AMOUNT OF CITICOLINE AND AT LEAST A SECOND THERAPEUTIC AGENT, OR THEIR RESPECTIVE PHARMACEUTICALLY ACCEPTABLE SALTS, IN A PHARMACEUTICALLY ACCEPTABLE CARRIER. |
priorityDate | 1995-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Predicate | Subject |
---|---|
isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419589196 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13804 |
Total number of triples: 16.